Clinical Trial Detail

NCT ID NCT01818986
Title Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

prostate cancer

Therapies

Sipuleucel-T

Age Groups: adult

No variant requirements are available.